Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases

Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases

Abstract Background Malignant peritoneal mesothelioma (MPM) is a rare malignant tumor with a high mortality rate and extremely poor prognosis. In-depth pathological analysis is essential to assess tumor biological behaviors and explore potential therapeutic targets of MPM. Nucleoplasmin 2 (NPM2) is...

Full description

Bibliographic Details
Main Authors: He-liang Wu, Zhi-ran Yang, Yan-dong Su, Ru Ma, Xue-mei Du, Ying Gao, Yan Li
Format: Article
Language:English
Published: BMC 2022-10-01
Series:World Journal of Surgical Oncology
Subjects:
Malignant peritoneal mesothelioma
Nucleoplasmin 2
QuPath software
Immunohistochemistry
Prognosis
Online Access:https://doi.org/10.1186/s12957-022-02811-y

Internet

https://doi.org/10.1186/s12957-022-02811-y

Similar Items